Tag Archives: Anavex

Anavex Life Sciences Corp (NASDAQ:AVXL), the clinical stage biopharmaceutical developing treatments for neurodegenerative and neurodevelopmental diseases, has been recently under the radar of many institutional investors. We assessed the company...

While the shorts continue their in-vein efforts to beat down on Anavex Life Sciences Corp. (NASDAQ:AVXL), the company continues to hold it’s own in the markets. At last count, Anavex traded for a little over $5.82 (pre market on Tuesday),...

Anavex Life Sciences Corp. (NASDAQ:AVXL) is one of the companies that we have repeatedly pitched as having a bright future, against a backdrop of our competitors over at The Street and Fool repeatedly painting the company as a sure thing short....

For the last eighteen months, Anavex Life Sciences Corp. (NASDAQ:AVXL) has been at the the center of a great debate. From the company falling foul of an army of short sellers, to management overpaying themselves, to the science being made up,...

While the majority of our competitors have warned investors away from Anavex Life Sciences Corp. (NASDAQ:AVXL) over the last six months, here at Insider Financial we have repeatedly highlighted the company as having the potential to offer investors...

Towards the end of last year, we highlighted Anavex Life Sciences Corp. (NASDAQ:AVXL) as being a company to keep an eye on. Prior to our December coverage, we had actually highlighted the company on a couple of occasions, suggesting that market...

Anavex Life Sciences Corp. (NASDAQ:AVXL) is picking up strength on the back of a corporate update, which offered a high degree of clarity in to the company’s numbers and operations ahead of what looks set to be a pivotal 2017 for the...

One of our most closely watched biotechs is Anavex Life Sciences Corp. (NASDAQ:AVXL). The company is a development stage biotech working to bring an alternative form of the current in-development Alzheimer’s treatments to market. It has...

In contrast to a number of our competitors, here at Insider Financial we’ve championed Anavex Life Sciences Corp (NASDAQ:AVXL) on a number of occasions in the recent past. The company is developing an Alzheimer’s therapy with a...

Anavex Life Sciences Corp. (NASDAQ:AVXL) has been one of our favorite small-cap biotech stocks here at Insider Financial for a while now. We have covered the company on numerous occasions in the past, and while there have been some spikes in...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter